We herein present an overview of the upcoming 5th edition of the World Health Organization
Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid …

Primary cutaneous lymphomas are a heterogeneous group of T-and B-cell lymphomas that
present in the skin with no evidence of extracutaneous disease at the time of diagnosis. The …

PURPOSE Patients with indolent non-Hodgkin lymphoma typically respond well to first-line
immunochemotherapy. At relapse, single-agent rituximab is commonly administered. Data …

Collectively, lymphoid neoplasms are the fourth most common cancer and the sixth leading
cause of cancer death in the United States. The authors provide contemporary lymphoid …

Background Waldenström's macroglobulinemia is an incurable, IgM-secreting
lymphoplasmacytic lymphoma (LPL). The underlying mutation in this disorder has not been …

Purpose To evaluate the prognostic impact of cell-of-origin (COO) subgroups, assigned
using the recently described gene expression–based Lymph2Cx assay in comparison with …

Diffuse large B-cell lymphoma (DLBCL) constitutes 30%–58% of non-Hodgkin's lymphoma
series. The crude incidence in Europe is 3.8/100 000/year [1]. The incidence increases with …

B cell lymphomas are cancers that arise from cells that depend on numerous highly
orchestrated interactions with immune and stromal cells in the course of normal …

Ulcerated lesions of the oral cavity have many underlying etiologic factors, most commonly
infection, immune related, traumatic, or neoplastic. A detailed patient history is critical in …

Background Multiple myeloma is a malignant disease of plasma cells with a worldwide
incidence of 6–7 cases per 100 000 persons per year. It is among the 20 most common …